Latham & Watkins has advised Intuitive Ventures on the deal. Osborne Clarke has advised Optellum. Higgs LLP advised Mercia. Optellum executed its US$14 million Series A funding...
Optellum’s $14 Million Series A Funding Round
Toqio’s €18.7 Million Series A Financing
Latham & Watkins advised Toqio on the deal. Osborne Clarke advised AlbionVC. The fast-growing fintech SaaS provider Toqio closed its €18.7 million Series A funding round....
CloudFactory’s Acquisition of Hasty
Osborne Clarke has advised CloudFactory on the deal. CloudFactory, a global leader in human-in-the-loop artificial intelligence (AI), acquired Hasty, a data-centric machine learning (ML) platform that...
Proximie’s US$80 Million Series C Equity Financing
Osborne Clarke advised Advent Life Sciences on the deal. Advent Life Sciences, one of the leading transatlantic venture investors building innovative life sciences businesses, made a lead...
Heqet Therapeutics’ €8 Million Series A Round Financing
McDermott, Will & Emery advised the investors, while Osborne Clarke advised King’s College in London. Heqet Therapeutics, a Turin-based start-up (a biotech spin-out from King’s College...
NeRRe Therapeutics’ £20 Million Series B2 Financing Round
Osborne Clarke advised NeRRe Therapeutics on the deal. The financing involved a syndicate of leading transatlantic life sciences investors led by new investor Columbus Venture Partners...